Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q3 2026 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2026-11-02

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q3 2026 (← Previous)

Filing Date: Nov 2, 2026

Total Value: $127M (100.0% shares, 0.0% debt)

Holdings (3)

Decreased Positions (1)

NAMS NEWAMSTERDAM PHARMA COMPANY 41.9%

Value $53.07M (-29.1%) Shares 2,182,339 (-1.2%) Share Price $24.32 Est. Cost/Share $10.96 Unrealized @ Report Date +122.0%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,182,339 (-1.2%)	$53.07M (-29.1%)	41.9%	$24.32	$10.96	+122.0%	ORDINARY SHARES	N62509109

Unchanged Positions (2)

PHAT PHATHOM PHARMACEUTICALS INC 43.0%

Value $54.49M Shares 7,464,572 Share Price $7.30 Est. Cost/Share $13.72 Unrealized @ Report Date -46.8%

AURA AURA BIOSCIENCES INC 15.1%

Value $19.09M Shares 3,039,892 Share Price $6.28 Est. Cost/Share $17.87 Unrealized @ Report Date -64.9%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$54.49M	43.0%	$7.30	$13.72	-46.8%	COM	71722W107
AURA	AURA BIOSCIENCES INC	3,039,892	$19.09M	15.1%	$6.28	$17.87	-64.9%	COM	05153U107